BERWYN, PA — AscellaHealth has reaffirmed its dedication to the 300 million individuals worldwide impacted by rare diseases in recognition of Rare Disease Day. Observed annually on the last day of February, the global initiative highlights the importance of awareness, equitable access to care, and unity within rare disease communities.
“The mission of AscellaHealth is closely aligned with the goals of Rare Disease Day, placing patients at the forefront and standing in solidarity with the rare disease community,” said Dea Belazi, CEO of AscellaHealth. “Every day, our team advances clinical programs and services to support rare disease research, expedite treatment, and enhance access to life-changing therapies.”
Specializing in end-to-end solutions, AscellaHealth collaborates with global pharmaceutical manufacturers to accelerate the discovery and commercialization of therapies, including innovative cell and gene treatment options. Their efforts include working with payers to develop reimbursement strategies that address the high cost of rare disease treatments, ensuring broader access and improved outcomes for patients.
To celebrate Rare Disease Day, AscellaHealth released a special episode of its Podcast Pulse series, sharing inspiring stories of resilience from patients supported by the company’s care coordinators. The podcast amplifies patient voices and emphasizes AscellaHealth’s commitment to advancing rare disease care.
Looking ahead, AscellaHealth remains focused on improving therapeutic access and driving innovation in rare disease treatment, offering hope and meaningful support to millions of individuals worldwide.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.